Central Nervous System Tumor
📧 Sign up to get email alerts when something new happens for Central Nervous System Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-02-09Clinical Trial Update: OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas [Phase 1]
A Phase 1 pilot trial of OXC401 (fosbretabulin) with bevacizumab for recurrent high-grade gliomas has been withdrawn. The study involves cen…
-
CLINICAL_TRIALS withdrawal · 2013-04-19Clinical Trial Update: Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors
A pediatric clinical trial investigating cerebrospinal fluid and angiogenesis proteins in newly diagnosed brain and central nervous system t…